Global Drug Testing Market Valued at $9.8 billion in 2025, Set to Grow at a 4.3% CAGR

Drug testing market was valued at $9.8 billion in 2025 and is projected to reach $14.8 billion by 2035, growing at a CAGR of 4.3% during the forecast Period (2026-2035). Regulatory approvals, such as FDA clearances, facilitate the adoption of validated testing technologies by ensuring standardization and enhancing trust in results, thereby promoting market growth across various sectors, including laboratories, hospitals, law enforcement, and treatment centers. For instance, in February 2026, FDA 510(k) the US Food and Drug Administration granted 510(k) clearance to a new clinical drug testing panel developed by Randox. The device, integrated into the Evidence MultiSTAT automated analyser, enables simultaneous detection of 15 drugs of abuse from urine samples in about 21 minutes, with pre?filled reagent cartridges and simplified operation aimed at improving clinical drug screening efficiency and accuracy.

Browse the full report description of “Drug Testing Market Size, Share & Trends Analysis by Component (Consumables, Instruments, and Rapid Testing Devices), By Sample Type (Urine Samples, Oral Fluid / Saliva Samples, Hair Samples, Blood Samples, and Others), By Drug Type (Alcohol, Cannabis / Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, and Other Drug Types), By End-User (Drug Testing Laboratories, Workplaces / Occupational Testing, Hospitals & Clinics, Criminal Justice / Law Enforcement, Drug Treatment Centers, and Other End Users ), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/drug-testing-market

Regulatory Support and Compliance Requirements

• In February 2026, the FDA announced it planned to drop its longstanding two?study requirement for new drug approvals, generally allowing a single robust clinical study to suffice for many applications. This policy is intended to accelerate drug development timelines, which could indirectly influence drug safety evaluation and screening processes in clinical practice.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Component
  • By Sample Type
  • BY Drug Type
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Abbott Laboratories, F. Hoffmann-La Roche Ltd., LabCorp (Laboratory Corporation of America Holdings), Quest Diagnostics Inc., Thermo Fisher Scientific Inc., among others

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Drug Testing Market Report Segment

By Component

• Consumables
• Instruments
• Rapid Testing Devices

By Sample Type

• Urine Samples
• Oral Fluid / Saliva Samples
• Hair Samples
• Blood Samples
• Others (Sweat, Breath)

By Drug Type

• Alcohol
• Cannabis / Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Other Drug Types (Benzodiazepines)

By End User

• Drug Testing Laboratories
• Workplaces / Occupational Testing
• Hospitals & Clinics
• Criminal Justice / Law Enforcement
• Drug Treatment Centers
• Other End Users (Schools, Individual Testing)

Global Drug Testing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/drug-testing-market